The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $124.66

Today's change-0.26 -0.21%
Updated March 30 4:01 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $124.66

Today's change-0.26 -0.21%
Updated March 30 4:01 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson down (U.S.)$0.26

Johnson & Johnson closed lower Thursday, dropping (U.S.)$0.26 or 0.21% to (U.S.)$124.66. Shares have lost 0.98% over the last five days, but sit 3.36% below their 52-week high. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $124.74
  • Previous close(U.S.) $124.92
  • High(U.S.) $125.43
  • Low(U.S.) $124.28
  • Bid / Ask-- / --
  • YTD % change+8.20%
  • Volume4,711,693
  • Average volume (10-day)7,138,414
  • Average volume (1-month)7,483,591
  • Average volume (3-month)7,108,935
  • 52-week range(U.S.) $107.69 to (U.S.) $129.00
  • Beta0.80
  • Trailing P/E21.00×
  • P/E 1 year forward17.75×
  • Forward PEG3.01×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.57%
  • Trailing EPS(U.S.) $5.94
Updated March 30 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.50%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 01, 201701/01/2017Oct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016
Revenue18,10617,82018,48217,482
Total other revenue--------
Total revenue18,10617,82018,48217,482
Gross profit12,59012,33713,15312,170
Total cost of revenue5,5165,4835,3295,312
Total operating expense13,78212,53913,57812,188
Selling / general / administrative5,3094,7725,1764,688
Research & development2,6402,1792,2632,013
Depreciation / amortization--------
Interest expense (income), net operating184192190160
Unusual expense (income)21365150137
Other operating expenses, total85-19593-37
Operating income4,3245,2814,9045,294
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4,3245,2814,9045,294
Income after tax3,8144,2723,9974,457
Income tax, total5101,009907837
Net income3,8144,2723,9974,457
Total adjustments to net income--------
Net income before extra. items3,8144,2723,9974,457
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,8144,2723,9974,457
Inc. avail. to common incl. extra. items3,8144,2723,9974,457
Diluted net income3,8144,2723,9974,457
Dilution adjustment--------
Diluted weighted average shares2,7662,7852,7942,798
Diluted EPS excluding extraordinary itemsvalue per share1.381.531.431.59
Dividends per sharevalue per share0.800.800.800.75
Diluted normalized EPSvalue per share1.361.521.441.60